Skip to main content
Top
Literature
1.
go back to reference Toy P, Popovsky MA, Abraham E et al (2005) Transfusion-related acute lung injury: definition and review. Crit Care Med 33:721–726CrossRefPubMed Toy P, Popovsky MA, Abraham E et al (2005) Transfusion-related acute lung injury: definition and review. Crit Care Med 33:721–726CrossRefPubMed
2.
go back to reference Bux J, Sachs UJ (2007) The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol 136:788–799CrossRefPubMed Bux J, Sachs UJ (2007) The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol 136:788–799CrossRefPubMed
3.
go back to reference Silliman CC, Boshkov LK, Mehdizadehkashi Z et al (2003) Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 101:454–462CrossRefPubMed Silliman CC, Boshkov LK, Mehdizadehkashi Z et al (2003) Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 101:454–462CrossRefPubMed
4.
go back to reference Looney MR, Su X, Van Ziffle JA et al (2006) Neutrophils and their Fc gamma receptors are essential in a mouse model of transfusion-related acute lung injury. J Clin Invest 116:1615–1623CrossRefPubMedPubMedCentral Looney MR, Su X, Van Ziffle JA et al (2006) Neutrophils and their Fc gamma receptors are essential in a mouse model of transfusion-related acute lung injury. J Clin Invest 116:1615–1623CrossRefPubMedPubMedCentral
5.
go back to reference Nishimura M, Hashimoto S, Takanashi M et al (2007) Role of anti-human leucocyte antigen class II alloantibody and monocytes in development of transfusion-related acute lung injury. Transfus Med 17:129–134CrossRefPubMed Nishimura M, Hashimoto S, Takanashi M et al (2007) Role of anti-human leucocyte antigen class II alloantibody and monocytes in development of transfusion-related acute lung injury. Transfus Med 17:129–134CrossRefPubMed
Metadata
Title
Transfusion Related Acute Lung Injury in a Platelet Refractory Neutropenic Patient
Authors
Puneet Jain
Nidhi Sharma
Sunil B. Rajadhyaksha
Meenakshi Singh
Publication date
01-09-2017
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 3/2017
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-016-0753-0

Other articles of this Issue 3/2017

Indian Journal of Hematology and Blood Transfusion 3/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine